Abstract | STUDY OBJECTIVE: DESIGN: Randomized, double-blinded, placebo-controlled study. SETTING: University hospital. PATIENTS: 100 ASA physical status I and II parturients undergoing cesarean delivery with spinal anesthesia. INTERVENTIONS: Patients received placebo (saline) followed by placebo ( Intralipid(R)), placebo (saline) followed by propofol at a subhypnotic dose (1.0 mg/kg/hr), droperidol 1.25 mg followed by placebo ( Intralipid(R)), or metoclopramide 10 mg followed by placebo ( Intralipid(R)) intravenously (IV) immediately after clamping of the umbilical cord. MEASUREMENT AND MAIN RESULTS: The percentage of patients who were emesis-free, which was defined as experiencing no nausea, retching, or vomiting, in the intraoperative, postdelivery period was 80% with propofol, 80% with droperidol, and 78% with metoclopramide (p < 0.05), compared with placebo (40%). Severity of nausea was less inpatients who received propofol than in those who received placebo (p < 0.05), and there were no differences seen among the droperidol, metoclopramide, and placebo groups. No clinically serious adverse events as a result of the study drugs were observed in any of the groups. CONCLUSIONS:
|
Authors | Mitsuko Numazaki, Yoshitaka Fujii |
Journal | Journal of clinical anesthesia
(J Clin Anesth)
Vol. 15
Issue 6
Pg. 423-7
(Sep 2003)
ISSN: 0952-8180 [Print] United States |
PMID | 14652118
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Retracted Publication)
|
Chemical References |
- Antiemetics
- Metoclopramide
- Droperidol
- Propofol
|
Topics |
- Adult
- Anesthesia, Obstetrical
- Anesthesia, Spinal
- Antiemetics
(administration & dosage)
- Cesarean Section
- Double-Blind Method
- Droperidol
(administration & dosage)
- Female
- Humans
- Metoclopramide
(administration & dosage)
- Postoperative Nausea and Vomiting
(prevention & control)
- Pregnancy
- Propofol
(administration & dosage)
|